Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted18F-DCFPyL positron emission tomography/computed tomography: A unique visual pattern

被引：2
|
作者：
Yin, Yafu [1 ,4 ]
Paller, Channing J. [2 ]
Pomper, Martin G. [1 ,2 ,3 ]
Pienta, Kenneth J. [2 ,3 ]
Gorin, Michael A. [1 ,2 ,3 ]
Rowe, Steven P. [1 ,3 ]
机构：
[1] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sidney Kimmell Comprehens Canc Ctr, Dept Oncol, Sch Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD USA
[4] China Med Univ, Hosp 1, Dept Nucl Med, Shenyang, Liaoning, Peoples R China
来源：
WORLD JOURNAL OF NUCLEAR MEDICINE | 2019年 / 18卷 / 04期
基金：
美国国家卫生研究院;
关键词：
18F-DCFPyL; positron emission tomography; computed tomography; prostate cancer; prostate-specific membrane; vas deferens;
D O I：
10.4103/wjnm.WJNM_50_18
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
New radiotracers for positron emission tomography imaging that target prostate-specific membrane antigen (PSMA) have emerged as important clinical tools for imaging prostate cancer (PCa). PSMA-targeted radiotracers have demonstrated high sensitivity and high specificity for detecting sites of PCa and are demonstrably superior to conventional imaging modalities such as computed tomography and bone scan. Vas deferens invasion is a rarely encountered poor prognostic feature of PCa. In this case report, we describe a novel pattern of radiotracer uptake in a patient with PCa imaged with PSMA-targeted18F-DCFPyL positron emission tomography/computed tomography that is consistent with diffuse vas deferens involvement.
引用
收藏
页码：424 / 427
页数：4
相关论文
共 50 条
  • [41] Prostate-Specific Membrane Antigen Positron Emission Tomography and the New Algorithm for Patients With Prostate Cancer Prior to Prostatectomy
    Osborne, Joseph R.
    Bander, Neil H.
    Tagawa, Scott T.
    JAMA ONCOLOGY, 2021, 7 (11) : 1642 - 1643
  • [42] Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
    Tateishi, Ukihide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 349 - 356
  • [43] Bringing clarity or confusion? The role of prostate-specific membrane antigen positron-emission/computed tomography for primary staging in prostate cancer
    Murphy, Declan G.
    Hofman, Michael
    Lawrentschuk, Nathan
    Maurer, Tobias
    BJU INTERNATIONAL, 2017, 119 (02) : 194 - 195
  • [44] New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography
    Afaq, Asim
    Batura, Deepak
    Bomanji, Jamshed
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (05) : 803 - 810
  • [45] New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography
    Asim Afaq
    Deepak Batura
    Jamshed Bomanji
    International Urology and Nephrology, 2017, 49 : 803 - 810
  • [46] 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and 68Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging in the Evaluation of Rare Entity Adult Embryonal Rhabdomyosarcoma of Prostate
    Gondhane, Abhay Indrasingh
    Verma, Priyanka
    Paul, Amal
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (01): : 66 - 68
  • [47] The Role of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography in the Management of Patients With Prostate Cancer: Implications for Selection of Patients for Radiation Therapy
    Amit, U.
    Goldstein, J. D.
    Davidson, T.
    Hahiashvili, M.
    Goshen, E.
    Oksman, Y.
    Berger, R.
    Saad, A.
    Sadetsky, I.
    Chikman, B.
    Lawrence, Y. R.
    Ben-Haim, S.
    Symon, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S112 - S113
  • [48] Diagnostic performance of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography in intermediate and high risk prostate cancer
    El Hajj, Albert
    Yacoub, Basel
    Mansour, Mazen
    Khauli, Raja
    Bulbul, Mohamad
    Nassif, Samer
    Haidar, Mohamad B.
    MEDICINE, 2019, 98 (44) : e17491
  • [49] Prospective Evaluation of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer Diagnosis
    Lopci, Egesta
    Lughezzani, Giovanni
    Castello, Angelo
    Saita, Alberto
    Colombo, Piergiuseppe
    Hurle, Rodolfo
    Peschechera, Roberto
    Benetti, Alessio
    Zandegiacomo, Silvia
    Pasini, Luisa
    Casale, Paolo
    Pietro, Diana
    Bevilacqua, Giulio
    Balzarini, Luca
    Buffi, Nicolo Maria
    Guazzoni, Giorgio
    Lazzeri, Massimo
    EUROPEAN UROLOGY FOCUS, 2021, 7 (04): : 764 - 771
  • [50] Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer Comment
    O'Brien, Jonathan S.
    McVey, Aoife
    Kelly, Brian D.
    Jenjitranant, Pocharapong
    Buteau, James
    Hofman, Michael S.
    Kasivisvanithan, Veeru
    Eapen, Renu
    Moon, Daniel
    Murphy, Declan G.
    Lawrentschuk, Nathan
    BJU INTERNATIONAL, 2022, 130 : 8 - 10
12345